Predict your next investment

HEALTHCARE | Drug Development
peptimmune.com

See what CB Insights has to offer

Executives

3

Peptimmune Management Team

3 Team Members

Peptimmune has 3 executives. Peptimmune's founder is Benjamin Bronstein. Peptimmune's former President is Thomas Mathers.

Name

Work History

Title

Status

Benjamin Bronstein

Aclaris Therapeutics, Sentien Biotechnologies, Stealth BioTherapeutics, Weill Cornell Medicine, OPKO Health, Spherics, Zero Stage Capital, Biosurface Technology, and Massachusetts General Hospital

Founder

Current

Thomas Mathers

President

Former

Louis J. Arcudi III

Senior Vice President

Former

Name

Benjamin Bronstein

Thomas Mathers

Louis J. Arcudi III

Work History

Aclaris Therapeutics, Sentien Biotechnologies, Stealth BioTherapeutics, Weill Cornell Medicine, OPKO Health, Spherics, Zero Stage Capital, Biosurface Technology, and Massachusetts General Hospital

Title

Founder

President

Senior Vice President

Status

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.